These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 2784652)

  • 21. Vaccines consisting of periodate-cleaved oligosaccharides from the capsule of Haemophilus influenzae type b coupled to a protein carrier: structural and temporal requirements for priming in the human infant.
    Anderson PW; Pichichero ME; Insel RA; Betts R; Eby R; Smith DH
    J Immunol; 1986 Aug; 137(4):1181-6. PubMed ID: 3016088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on the combined administration of Haemophilus influenzae type B--diphtheria toxoid conjugate vaccine (PRP-D) and DTP.
    Gordon LK
    Dev Biol Stand; 1986; 65():113-21. PubMed ID: 3549393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunization of children with sickle cell disease with Haemophilus influenzae type b polysaccharide vaccine.
    Rubin LG; Voulalas D; Carmody L
    Pediatrics; 1989 Sep; 84(3):509-13. PubMed ID: 2788866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haemophilus influenzae type b immunization in infants in the United Kingdom: effects of diphtheria/tetanus/acellular pertussis/Hib combination vaccine, significant prematurity, and a fourth dose.
    Berrington JE; Cant AJ; Matthews JN; O'Keeffe M; Spickett GP; Fenton AC
    Pediatrics; 2006 Apr; 117(4):e717-24. PubMed ID: 16549502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity and reactogenicity of a three-dose primary vaccination course with a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-haemophilus influenzae type b vaccine coadministered with a meningococcal C conjugate vaccine.
    Tejedor JC; Omeñaca F; García-Sicilia J; Verdaguer J; Van Esso D; Esporrín C; Molina V; Muro M; Marés J; Enrubia M; Moraga F; García-Corbeira P; Dobbelaere K; Schuerman L;
    Pediatr Infect Dis J; 2004 Dec; 23(12):1109-15. PubMed ID: 15626947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and immunogenicity of haemophilus influenzae type B polysaccharide or conjugate vaccines in an elderly adult population.
    Lottenbach KR; Granoff DM; Barenkamp SJ; Powers DC; Kennedy D; Irby-Moore S; Homan SM; Mink CM
    J Am Geriatr Soc; 2004 Nov; 52(11):1883-7. PubMed ID: 15507066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity study of Haemophilus influenzae type B conjugate vaccine in Indian infants.
    Phadke MA; Kulkarni MV; Sovani VB; Lokeshwar MR; Venkataraman R
    Indian Pediatr; 1997 Sep; 34(9):779-83. PubMed ID: 9492415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age-dependent V region expression in the human antibody response to the Haemophilus influenzae type b polysaccharide.
    Lucas AH; Azmi FH; Mink CM; Granoff DM
    J Immunol; 1993 Mar; 150(5):2056-61. PubMed ID: 8436834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of Haemophilus influenzae type b colonization by vaccination: correlation with serum anti-capsular IgG concentration.
    Fernandez J; Levine OS; Sanchez J; Balter S; LaClaire L; Feris J; Romero-Steiner S
    J Infect Dis; 2000 Nov; 182(5):1553-6. PubMed ID: 11023481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antipolyribosyl ribitol phosphate response of premature infants to primary and booster vaccination with a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio virus/Haemophilus influenzae type b vaccine.
    Omeñaca F; Garcia-Sicilia J; García-Corbeira P; Boceta R; Torres V
    Pediatrics; 2007 Jan; 119(1):e179-85. PubMed ID: 17145903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of intravenous gammaglobulin therapy in IgG2 deficient and IgG2 sufficient children with recurrent infections and poor response to immunization with Hemophilus influenzae type b capsular polysaccharide antigen.
    Silk HJ; Ambrosino D; Geha RS
    Ann Allergy; 1990 Jan; 64(1):21-5. PubMed ID: 2297141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors influencing immunogenicity and safety of two Haemophilus influenzae type b polysaccharide vaccines in children 18 and 24 months of age.
    Greenberg DP; Ward JI; Burkart K; Christenson PD; Guravitz L; Marcy SM
    Pediatr Infect Dis J; 1987 Jul; 6(7):660-5. PubMed ID: 3497380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Capsular polysaccharide Haemophilus influenzae type b vaccine: clinical and immunologic responses to two vaccines.
    Barkin RM; Hendley JO; Zahradnik J; McVerry P; Samuelson JS
    Pediatr Infect Dis J; 1987 Jan; 6(1):20-3. PubMed ID: 3493475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of comparability between commonly used serological assays of immune response to Haemophilus influenzae vaccine.
    Edwards KM; Decker MD; Palmer P; Porch CR; Sell SH; Wright PF
    J Infect Dis; 1987 Feb; 155(2):283-91. PubMed ID: 3492571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody of polyribophate of Haemophilus influenzae type b in infants and children: effect of immunization with polyribophosphate.
    Anderson P; Smith DH; Ingram DL; Wilkins J; Wehrle PF; Howie VM
    J Infect Dis; 1977 Aug; 136 Suppl():S57-62. PubMed ID: 302291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subcutaneous versus intramuscular administration of Haemophilus influenzae type b vaccine.
    Leung AK; Chiu AS; Siu TO
    J R Soc Health; 1989 Apr; 109(2):71-3. PubMed ID: 2500525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of the Haemophilus influenzae type b vaccine among preschool attendees.
    Gilsdorf JR
    Clin Pediatr (Phila); 1988 Jun; 27(6):285-8. PubMed ID: 3259486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mucosal antibody response to parenteral vaccination with Haemophilus influenzae type b capsule.
    Pichichero ME; Insel RA
    J Allergy Clin Immunol; 1983 Nov; 72(5 Pt 1):481-6. PubMed ID: 6605372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hib vaccine efficacy trials continue; data needed about use in younger children.
    Marwick C
    JAMA; 1989 Apr; 261(14):2015, 2019. PubMed ID: 2648039
    [No Abstract]   [Full Text] [Related]  

  • 40. [Tolerance and immunogenicity of the capsular polyoside vaccine against Haemophilus influenzae type b. A study of 325 children 15 to 71 months of age].
    Reinert P; Postel-Vinay A; Bessa E; Hessel L; Schulz D; Cadoz M
    Ann Pediatr (Paris); 1989 Jan; 36(1):20-5. PubMed ID: 2784652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.